Trial record 1 of 1 for: NCT00932893
Previous Study | Return to List | Next Study
An Investigational Drug, PF-02341066 Is Being Studied Versus Standard Of Care In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene
This study has been completed.
First Posted: July 3, 2009
Last Update Posted: January 2, 2017
Information provided by (Responsible Party):